WASHINGTON, Jan. 21, 2026 /PRNewswire/ — The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to supportWASHINGTON, Jan. 21, 2026 /PRNewswire/ — The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to support

DIA Launches ASCENT Platform and LIFT Biotech & Startup Program to Accelerate Emerging Innovation

WASHINGTON, Jan. 21, 2026 /PRNewswire/ — The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to support early-stage biotechnology drug development innovation, along with its inaugural initiative, the LIFT (Linking Innovation, Funding, and Translation) Series. Together, ASCENT and LIFT create a structured, multi-stage pathway to educate, prepare, and connect emerging biotech and startup companies with investors, regulators, pharma leaders, and development organizations across the full product lifecycle.

DIA announces ASCENT and LIFT Series to advance early-stage biotech innovation and collaboration.

Built to address persistent barriers facing early-stage innovators, such as limited investor access, fragmented access to expertise, and unclear regulatory pathways, and steep execution gaps, ASCENT extends DIA’s role as a trusted, multi-stakeholder convener to the earliest phases of innovation. Through curated education, mentorship, regulatory insight, and global exposure, the platform aims to strengthen the life sciences innovation pipeline worldwide.

The DIA LIFT Series unfolds across three integrated program offerings in 2026. Phase I launches with a Virtual Masterclass Series beginning in February 2026, featuring expert-led sessions with case studies focused on fund-raising, drug development including the role of AI, regulatory strategy, clinical development and financial modeling.

Phase II brings LIFT Series to DIA Europe 2026 in Rotterdam, Netherlands (March 24–26, 2026), with dedicated LIFT Programming for Biotech & Startups embedded within a globally attended meeting of more than 2,500 professionals. Programming includes expert coaching, live pitch competitions, regulator and investor roundtables, and curated networking opportunities.

Phase III culminates at the DIA 2026 Global Annual Meeting  in Philadelphia, Pennsylvania (June 14–18, 2026), featuring expanded LIFT Series Biotech & Startup programming, a Startup Row, and two targeted pitch events focused on drug and therapy development and techbio innovation, all within a 4,000+ attendee global forum.

“Our mission has always been to convene the global life sciences community to improve health worldwide,” said Marwan Fathallah, CEO of DIA. “With ASCENT and the LIFT Series Program, we are extending that mission earlier in the innovation journey providing emerging companies with the insight, connections, and visibility needed to advance promising science and strengthen the entire ecosystem.”

Registration for the LIFT Virtual Masterclass Series is now open. Details for Annual Meeting registrations and pitch competitions is available with pitch applications opening soon.

To learn more, visit: https://connect.diaglobal.org/dia-ascent-1

About DIA

DIA is a leading global non-profit life science membership association that drives collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries.

Learn more at DIAglobal.org.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dia-launches-ascent-platform-and-lift-biotech–startup-program-to-accelerate-emerging-innovation-302665447.html

SOURCE Drug Information Association

Market Opportunity
Startup Logo
Startup Price(STARTUP)
$0.0001636
$0.0001636$0.0001636
+1.99%
USD
Startup (STARTUP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

XMR Technical Analysis Jan 22

XMR Technical Analysis Jan 22

The post XMR Technical Analysis Jan 22 appeared on BitcoinEthereumNews.com. XMR, despite the general downtrend, holding above short-term EMA20 at the $514.37 level
Share
BitcoinEthereumNews2026/01/22 14:13
UK and US Seal $42 Billion Tech Pact Driving AI and Energy Future

UK and US Seal $42 Billion Tech Pact Driving AI and Energy Future

The post UK and US Seal $42 Billion Tech Pact Driving AI and Energy Future appeared on BitcoinEthereumNews.com. Key Highlights Microsoft and Google pledge billions as part of UK US tech partnership Nvidia to deploy 120,000 GPUs with British firm Nscale in Project Stargate Deal positions UK as an innovation hub rivaling global tech powers UK and US Seal $42 Billion Tech Pact Driving AI and Energy Future The UK and the US have signed a “Technological Prosperity Agreement” that paves the way for joint projects in artificial intelligence, quantum computing, and nuclear energy, according to Reuters. Donald Trump and King Charles review the guard of honour at Windsor Castle, 17 September 2025. Image: Kirsty Wigglesworth/Reuters The agreement was unveiled ahead of U.S. President Donald Trump’s second state visit to the UK, marking a historic moment in transatlantic technology cooperation. Billions Flow Into the UK Tech Sector As part of the deal, major American corporations pledged to invest $42 billion in the UK. Microsoft leads with a $30 billion investment to expand cloud and AI infrastructure, including the construction of a new supercomputer in Loughton. Nvidia will deploy 120,000 GPUs, including up to 60,000 Grace Blackwell Ultra chips—in partnership with the British company Nscale as part of Project Stargate. Google is contributing $6.8 billion to build a data center in Waltham Cross and expand DeepMind research. Other companies are joining as well. CoreWeave announced a $3.4 billion investment in data centers, while Salesforce, Scale AI, BlackRock, Oracle, and AWS confirmed additional investments ranging from hundreds of millions to several billion dollars. UK Positions Itself as a Global Innovation Hub British Prime Minister Keir Starmer said the deal could impact millions of lives across the Atlantic. He stressed that the UK aims to position itself as an investment hub with lighter regulations than the European Union. Nvidia spokesman David Hogan noted the significance of the agreement, saying it would…
Share
BitcoinEthereumNews2025/09/18 02:22
‘If you want to be great, make enemies’: Solana economist Max Resnick

‘If you want to be great, make enemies’: Solana economist Max Resnick

The post ‘If you want to be great, make enemies’: Solana economist Max Resnick  appeared on BitcoinEthereumNews.com. Max Resnick, the Consensys researcher who publicly
Share
BitcoinEthereumNews2026/01/22 14:12